DHR Danaher Corporation

Q1 2025 10-Q

Filed: Apr 22, 2025Period ending Mar 28, 2025

Health Care

Industrial Instruments For Measurement, Display, and ControlSEC EDGAR

Danaher Corporation (DHR) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on Apr 22, 2025 for the fiscal period ending Mar 28, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q1 2025 10-Q

Risk Factors

• Newly added trade tariff risk triggered by recent U.S. and retaliatory tariffs with China, increasing supply costs and potentially reducing product demand
• Materially updated supply chain risk due to ongoing tariffs causing potential product availability issues and operational disruptions

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$5.7B

Net Income

$954M

Gross Margin

61.2%

Operating Margin

22.2%

Net Margin

16.6%

Source: XBRL data from Danaher Corporation Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Danaher Corporation Quarterly Reports

Q3 2025 10-Q

Q2 2025 10-Q

Get deeper insights on Danaher Corporation

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.